Engineering stealth delivery systems for the human body
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
We build hollow nanoparticles that carry DNA, RNA, proteins, and small molecules safely into cells, protecting the payload from immune detection and enabling precise gene therapy.
We engineer what the body cannot
Our proprietary hollow-core nanoparticle acts as a carrier capsule.
It shields sensitive genetic material from immune exposure and releases it directly into target cells.
A new framework for safe, repeatable, and programmable gene delivery.
Built for modern medicine
meet the founders
The minds shaping the next generation of Delivery.
.png)
Aydin Gokce
CEO•board
Foresight Fellow and early Saronic team member with experience building frontier-technology organizations from zero to scale. At Cathedral, he leads the company’s vision, strategy, and cross-disciplinary execution.
David Curiel, MD, PhD
SAB•board
A leader in gene therapy with 40+ years of research and over 64,000 citations, David provides scientific guidance as Cathedral advances the future of genetic medicine.
Logan Thrasher Collins
SAB•board
The scientific mind behind Cathedral’s platform, Logan has been an exceptional innovator since designing a novel antibiotic at 16 and continues to push the boundaries of synthetic biology.
Harrison Wang
Head of R&D
Biotech R&D leader with a track record of advancing therapeutic programs from concept toward clinical readiness, guiding scientific strategy, development, and cross-functional execution across Cathedral’s platform.
Sebastian Valerio, PhD
PrA
With over a decade of biotechnology experience across Harvard and ANU, Sebastian drives scientific development and supports core research across Cathedral’s platform
